Multicenter open-label RCT to compare colistin alone vs. colistin plus meropenem Trial [randomizzato controllato multicentrico per la valutazione dell'efficacia di colistina rispetto a colistina e meropenem nel trattamento delle infezioni severe da batteri gram negativi multi resistenti]

Trial Profile

Multicenter open-label RCT to compare colistin alone vs. colistin plus meropenem Trial [randomizzato controllato multicentrico per la valutazione dell'efficacia di colistina rispetto a colistina e meropenem nel trattamento delle infezioni severe da batteri gram negativi multi resistenti]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2013

At a glance

  • Drugs Colistin (Primary) ; Meropenem (Primary)
  • Indications Gram-negative infections
  • Focus Therapeutic Use
  • Acronyms AIDA
  • Most Recent Events

    • 18 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top